Cromoglycate drugs suppress eicosanoid generation in U937 cells by promoting the release of Anx-A1

Biochemical Pharmacology

Volumn 77, Issue 12, 2009, Pages 1814-1826

  Yazid, Samia ^a   Solito, Egle ^b   Christian, Helen ^c   McArthur, Simon ^b   Goulding, Nicolas ^a   Flower, Roderick ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b Faculty of Medicine   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Glucocorticoids; Okadaic acid; PKC; PP2A phosphatase; Sodium nedocromil

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; BETAMETHASONE; CROMOGLYCATE DISODIUM; DEXAMETHASONE; GLUCOCORTICOID; HYDROCORTISONE; ICOSANOID; LIPOCORTIN 1; METHYLPREDNISOLONE; MIFEPRISTONE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY ANNEXIN A1; NEDOCROMIL; PHOSPHOPROTEIN PHOSPHATASE; PREDNISOLONE; PROTEIN KINASE C ALPHA; PROTEIN KINASE C BETA; THROMBOXANE B2; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL MEMBRANE; CELL MIGRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENTIATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; INTRACELLULAR TRANSPORT; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION;

ANNEXIN A1; ANTI-ASTHMATIC AGENTS; CROMOLYN SODIUM; DRUG THERAPY, COMBINATION; EICOSANOIDS; GLUCOCORTICOIDS; HUMANS; NEDOCROMIL; PROTEIN KINASE C; PROTEIN PHOSPHATASE 2; PROTEIN TRANSPORT; U937 CELLS;

EID: 67349117733     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2009.03.010     Document Type: Article

References (108)

1. Cirino G., Cicala C., Sorrentino L., Ciliberto G., Arpaia G., Perretti M., et al. Anti-inflammatory actions of an N-terminal peptide from human lipocortin 1. Br J Pharmacol 108 (1993) 573-574
2. Perretti M., Ahluwalia A., Harris J.G., Goulding N.J., and Flower R.J. Lipocortin-1 fragments inhibit neutrophil accumulation and neutrophil-dependent edema in the mouse. A qualitative comparison with an anti-CD11b monoclonal antibody. J Immunol 151 (1993) 4306-4314
3. Perretti M., Appleton I., Parente L., and Flower R.J. Pharmacology of interleukin-1-induced neutrophil migration. Agents Actions 38 (1993) [Spec. No.:C64-5]
4. Perretti M., and Flower R.J. Modulation of IL-1-induced neutrophil migration by dexamethasone and lipocortin 1. J Immunol 150 (1993) 992-999
5. Cirino G., Peers S.H., Flower R.J., Browning J.L., and Pepinsky R.B. Human recombinant lipocortin 1 has acute local anti-inflammatory properties in the rat paw edema test. Proc Natl Acad Sci USA 86 (1989) 3428-3432
6. Perretti M., and Flower R.J. Anti-inflammatory lipocortin-derived peptides. Agents Actions Suppl 46 (1995) 131-138
7. Wu C.C., Croxtall J.D., Perretti M., Bryant C.E., Thiemermann C., Flower R.J., et al. Lipocortin 1 mediates the inhibition by dexamethasone of the induction by endotoxin of nitric oxide synthase in the rat. Proc Natl Acad Sci USA 92 (1995) 3473-3477
8. Harris J.G., Flower R.J., and Perretti M. Alteration of neutrophil trafficking by a lipocortin 1 N-terminus peptide. Eur J Pharmacol 279 (1995) 149-157
9. Mancuso F., Flower R.J., and Perretti M. Leukocyte transmigration, but not rolling or adhesion, is selectively inhibited by dexamethasone in the hamster post-capillary venule. Involvement of endogenous lipocortin 1. J Immunol 155 (1995) 377-386
10. Perretti M., and Flower R.J. Measurement of lipocortin 1 levels in murine peripheral blood leukocytes by flow cytometry: modulation by glucocorticoids and inflammation. Br J Pharmacol 118 (1996) 605-610
11. Ferreira S.H., Cunha F.Q., Lorenzetti B.B., Michelin M.A., Perretti M., Flower R.J., et al. Role of lipocortin-1 in the anti-hyperalgesic actions of dexamethasone. Br J Pharmacol 121 (1997) 883-888
12. Cuzzocrea S., Tailor A., Zingarelli B., Salzman A.L., Flower R.J., Szabo C., et al. Lipocortin 1 protects against splanchnic artery occlusion and reperfusion injury by affecting neutrophil migration. J Immunol 159 (1997) 5089-5097
13. Lim L.H., Solito E., Russo-Marie F., Flower R.J., and Perretti M. Promoting detachment of neutrophils adherent to murine postcapillary venules to control inflammation: effect of lipocortin 1. Proc Natl Acad Sci USA 95 (1998) 14535-14539
14. D'Amico M., Di Filippo C., La M., Solito E., McLean P.G., Flower R.J., et al. Lipocortin 1 reduces myocardial ischemia-reperfusion injury by affecting local leukocyte recruitment. FASEB J 14 (2000) 1867-1869
15. La M., D'Amico M., Bandiera S., Di Filippo C., Oliani S.M., Gavins F.N., et al. Annexin 1 peptides protect against experimental myocardial ischemia-reperfusion: analysis of their mechanism of action. FASEB J 15 (2001) 2247-2256
16. La M., Tailor A., D'Amico M., Flower R.J., and Perretti M. Analysis of the protection afforded by annexin 1 in ischaemia-reperfusion injury: focus on neutrophil recruitment. Eur J Pharmacol 429 (2001) 263-278
17. Bandeira-Melo C., Bonavita A.G., Diaz B.L., e Silva P.M.R., Carvalho V.F., Jose P.J., et al. A novel effect for annexin 1-derived peptide ac2-26: reduction of allergic inflammation in the rat. J Pharmacol Exp Ther 313 (2005) 1416-1422
18. Yang Y., Leech M., Hutchinson P., Holdsworth S.R., and Morand E.F. Antiinflammatory effect of lipocortin 1 in experimental arthritis. Inflammation 21 (1997) 583-596
19. Yang Y., Hutchinson P., and Morand E.F. Inhibitory effect of annexin I on synovial inflammation in rat adjuvant arthritis. Arthritis Rheum 42 (1999) 1538-1544
20. Yang Y.H., Morand E.F., Getting S.J., Paul-Clark M., Liu D.L., Yona S., et al. Modulation of inflammation and response to dexamethasone by Annexin 1 in antigen-induced arthritis. Arthritis Rheum 50 (2004) 976-984
21. Goulding N.J., Godolphin J.L., Sharland P.R., Peers S.H., Sampson M., Maddison P.J., et al. Anti-inflammatory lipocortin 1 production by peripheral blood leucocytes in response to hydrocortisone. Lancet 335 (1990) 1416-1418
22. Peers S.H., Smillie F., Elderfield A.J., and Flower R.J. Glucocorticoid-and non-glucocorticoid induction of lipocortins (annexins) 1 and 2 in rat peritoneal leucocytes in vivo. Br J Pharmacol 108 (1993) 66-72
23. Ahluwalia A., Mohamed R.W., and Flower R.J. Induction of lipocortin 1 by topical steroid in rat skin. Biochem Pharmacol 48 (1994) 1647-1654
24. Perretti M., Croxtall J.D., Wheller S.K., Goulding N.J., Hannon R., and Flower R.J. Mobilizing lipocortin 1 in adherent human leukocytes downregulates their transmigration. Nat Med 2 (1996) 1259-1262
25. Croxtall J.D., Choudhury Q., and Flower R.J. Glucocorticoids act within minutes to inhibit recruitment of signalling factors to activated EGF receptors through a receptor-dependent, transcription-independent mechanism. Br J Pharmacol 130 (2000) 289-298
26. John C.D., Christian H.C., Morris J.F., Flower R.J., Solito E., and Buckingham J.C. Kinase-dependent regulation of the secretion of thyrotrophin and luteinizing hormone by glucocorticoids and annexin 1 peptides. J Neuroendocrinol 15 (2003) 946-957
27. Solito E., Mulla A., Morris J.F., Christian H.C., Flower R.J., and Buckingham J.C. Dexamethasone induces rapid serine-phosphorylation and membrane translocation of annexin 1 in a human folliculostellate cell line via a novel nongenomic mechanism involving the glucocorticoid receptor, protein kinase C, phosphatidylinositol 3-kinase, and mitogen-activated protein kinase. Endocrinology 144 (2003) 1164-1174
28. Solito E., Christian H.C., Festa M., Mulla A., Tierney T., Flower R., et al. Post-translational modification plays an essential role in the translocation of annexin A1 from the cytoplasm to the cell surface. Faseb J 20 (2006) 1498-1500
29. Gavins F.N., Yona S., Kamal A.M., Flower R.J., and Perretti M. Leukocyte antiadhesive actions of annexin 1: ALXR- and FPR-related anti-inflammatory mechanisms. Blood 101 (2003) 4140-4147
30. Perretti M. Flower RJ. Annexin 1 and the biology of the neutrophil. J Leukoc Biol 76 (2004) 25-29
31. Hayhoe R.P., Kamal A.M., Solito E., Flower R.J., Cooper D., and Perretti M. Annexin 1 and its bioactive peptide inhibit neutrophil-endothelium interactions under flow: indication of distinct receptor involvement. Blood 107 (2006) 2123-2130
32. Cook E.B., Stahl J.L., Barney N.P., and Graziano F.M. Mechanisms of antihistamines and mast cell stabilizers in ocular allergic inflammation. Curr Drug Targets Inflamm Allergy 1 (2002) 167-180
33. Barnes P.J. Anti-inflammatory therapy for asthma. Annu Rev Med 44 (1993) 229-242
34. Viscardi R.M., Hasday J.D., Gumpper K.F., Taciak V., Campbell A.B., and Palmer T.W. Cromolyn sodium prophylaxis inhibits pulmonary proinflammatory cytokines in infants at high risk for bronchopulmonary dysplasia. Am J Respir Crit Care Med 156 (1997) 1523-1529
35. Bleecker E.R., Mason P.L., and Moore W.C. Clinical effects of nedocromil sodium on allergen-related mechanisms. J Allergy Clin Immunol 98 (1996) S118-S123 [discussion S40-2]
36. Cox J.S. Disodium cromoglycate (FPL 670) ('Intal'): a specific inhibitor of reaginic antibody-antigen mechanisms. Nature 216 (1967) 1328-1329
37. Cox J.S. Recent developments concerned with the mode of action of disodium cromoglycate (Intal). Arerugi 19 (1970) 832-835
38. Cox J.S., and Altounyan R.E. Nature and modes of action of disodium cromoglycate (Lomudal). Respiration 27 Suppl. (1970) 292-309
39. Cox J.S., Orr T.S., Pollard M.C., and Gwilliam J. Mode of action of disodium cromoglycate, studies on immediate type hypersensitivity reactions using 'double sensitization' with two antigenically distinct rat reagins. Clin Exp Immunol 7 (1970) 745-757
40. Orr T.S. Development of preclinical models for testing antiasthma drugs. Drugs 37 Suppl. 1 (1989) 113-116 [discussion 27-36]
41. Mattoli S., Mezzetti M., Fasoli A., Patalano F., and Allegra L. Nedocromil sodium prevents the release of 15-hydroxyeicosatetraenoic acid from human bronchial epithelial cells exposed to toluene diisocyanate in vitro. Int Arch Allergy Appl Immunol 92 (1990) 16-22
42. Radeau T., Godard P., Chavis C., Michel F.B., Descomps B., and Damon M. Effect of nedocromil sodium on sulfidopeptide leukotrienes-stimulated human alveolar macrophages in asthma. Pulm Pharmacol 6 (1993) 27-31
43. Solito E., Raugei G., Melli M., and Parente L. Dexamethasone induces the expression of the mRNA of lipocortin 1 and 2 and the release of lipocortin 1 and 5 in differentiated, but not undifferentiated U-937 cells. FEBS Lett 291 (1991) 238-244
44. Long F., Wang Y.X., Liu L., Zhou J., Cui R.Y., and Jiang C.L. Rapid nongenomic inhibitory effects of glucocorticoids on phagocytosis and superoxide anion production by macrophages. Steroids 70 (2005) 55-61
45. Lovell P.V., King J.T., and McCobb D.P. Acute modulation of adrenal chromaffin cell BK channel gating and cell excitability by glucocorticoids. J Neurophysiol 91 (2004) 561-570
46. Buttgereit F., Saag K.G., Cutolo M., da Silva J.A., and Bijlsma J.W. The molecular basis for the effectiveness, toxicity, and resistance to glucocorticoids: focus on the treatment of rheumatoid arthritis. Scand J Rheumatol 34 (2005) 14-21
47. Urbach V., Verriere V., Grumbach Y., Bousquet J., and Harvey B.J. Rapid anti-secretory effects of glucocorticoids in human airway epithelium. Steroids 71 (2006) 323-328
48. Lowenberg M., Tuynman J., Bilderbeek J., Gaber T., Buttgereit F., van Deventer S., et al. Rapid immunosuppressive effects of glucocorticoids mediated through Lck and Fyn. Blood 106 (2005) 1703-1710
49. Lowenberg M., Verhaar A.P., Bilderbeek J., Marle J., Buttgereit F., Peppelenbosch M.P., et al. Glucocorticoids cause rapid dissociation of a T-cell-receptor-associated protein complex containing LCK and FYN. EMBO Rep 7 (2006) 1023-1029
50. Seemann J., Weber K., and Gerke V. Annexin I targets S100C to early endosomes. FEBS Lett 413 (1997) 185-190
51. Bianchi R., Giambanco I., Arcuri C., and Donato R. Subcellular localization of S100A11 (S100C) in LLC-PK1 renal cells: calcium- and protein kinase c-dependent association of S100A11 with S100B and vimentin intermediate filaments. Microsc Res Tech 60 (2003) 639-651
52. Alldridge L.C., Harris H.J., Plevin R., Hannon R., and Bryant C.E. The annexin protein lipocortin 1 regulates the MAPK/ERK pathway. J Biol Chem 274 (1999) 37620-37628
53. Futter C.E., Felder S., Schlessinger J., Ullrich A., and Hopkins C.R. Annexin I is phosphorylated in the multivesicular body during the processing of the epidermal growth factor receptor. J Cell Biol 120 (1993) 77-83
54. White I.J., Bailey L.M., Aghakhani M.R., Moss S.E., and Futter C.E. EGF stimulates annexin 1-dependent inward vesiculation in a multivesicular endosome subpopulation. EMBO J (2005)
55. Morris J.F., Christian H.C., Chapman L.P., Epton M.J., Buckingham J.C., Ozawa H., et al. Steroid effects on secretion from subsets of lactotrophs: role of folliculo-stellate cells and annexin 1. Arch Physiol Biochem 110 (2002) 54-61
56. Chapman L.P., Epton M.J., Buckingham J.C., Morris J.F., and Christian H.C. Evidence for a role of the adenosine 5′-triphosphate-binding cassette transporter A1 in the externalization of annexin I from pituitary folliculo-stellate cells. Endocrinology 144 (2003) 1062-1073
57. Wein S., Fauroux M., Laffitte J., de Nadai P., Guaini C., Pons F., et al. Mediation of annexin 1 secretion by a probenecid-sensitive ABC-transporter in rat inflamed mucosa. Biochem Pharmacol 67 (2004) 1195-1202
58. Nickel W. Unconventional secretion: an extracellular trap for export of fibroblast growth factor 2. J Cell Sci 120 (2007) 2295-2299
59. Babiychuk E.B., Monastyrskaya K., and Draeger A. Fluorescent annexin A1 reveals dynamics of ceramide platforms in living cells. Traffic 9 (2008) 1757-1775
60. Qiu J., Wang C.G., Huang X.Y., and Chen Y.Z. Nongenomic mechanism of glucocorticoid inhibition of bradykinin-induced calcium influx in PC12 cells: possible involvement of protein kinase C. Life Sci 72 (2003) 2533-2542
61. Ishizuka T., Yamamoto M., Nagashima T., Kajita K., Taniguchi O., Yasuda K., et al. Effect of dexamethasone and prednisolone on insulin-induced activation of protein kinase C in rat adipocytes and soleus muscles. Metab Clin Exp 44 (1995) 298-306
62. Park S., Taub M., and Han H. Regulation of phosphate uptake in primary cultured rabbit renal proximal tubule cells by glucocorticoids: evidence for nongenomic as well as genomic mechanisms. Endocrinology 142 (2001) 710-720
63. Plotkin L.I., Manolagas S.C., and Bellido T. Glucocorticoids induce osteocyte apoptosis by blocking focal adhesion kinase-mediated survival. Evidence for inside-out signaling leading to anoikis. J Biol Chem 282 (2007) 24120-24130
64. Hansra G., Bornancin F., Whelan R., Hemmings B.A., and Parker P.J. 12-O-Tetradecanoylphorbol-13-acetate-induced dephosphorylation of protein kinase C alpha correlates with the presence of a membrane-associated protein phosphatase 2A heterotrimer. J Biol Chem 271 (1996) 32785-32788
65. Sim A.T., and Scott J.D. Targeting of PKA, PKC and protein phosphatases to cellular microdomains. Cell Calcium 26 (1999) 209-217
66. Boudreau R.T., Garduno R., and Lin T.J. Protein phosphatase 2A and protein kinase C alpha are physically associated and are involved in Pseudomonas aeruginosa-induced interleukin 6 production by mast cells. J Biol Chem 277 (2002) 5322-5329
67. Ricciarelli R., and Azzi A. Regulation of recombinant PKC alpha activity by protein phosphatase 1 and protein phosphatase 2A. Arch Biochem Biophys 355 (1998) 197-200
68. Lee I.H., Lim H.J., Yoon S., Seong J.K., Bae D.S., Rhee S.G., et al. Ahnak protein activates protein kinase C (PKC) through dissociation of the PKC-protein phosphatase 2A complex. J Biol Chem 283 (2008) 6312-6320
69. Zhang D., Kanthasamy A., Yang Y., Anantharam V., and Kanthasamy A. Protein kinase C delta negatively regulates tyrosine hydroxylase activity and dopamine synthesis by enhancing protein phosphatase-2A activity in dopaminergic neurons. J Neurosci 27 (2007) 5349-5362
70. Faulkner N.E., Lane B.R., Bock P.J., and Markovitz D.M. Protein phosphatase 2A enhances activation of human immunodeficiency virus type 1 by phorbol myristate acetate. J Virol 77 (2003) 2276-2281
71. Lee W.J., Kim D.U., Lee M.Y., and Choi K.Y. Identification of proteins interacting with the catalytic subunit of PP2A by proteomics. Proteomics 7 (2007) 206-214
72. Yoo S.J., Boylan J.M., Brautigan D.L., and Gruppuso P.A. Subunit composition and developmental regulation of hepatic protein phosphatase 2A (PP2A). Arch Biochem Biophys 461 (2007) 186-193
73. Ortega-Gutierrez S., Leung D., Ficarro S., Peters E.C., and Cravatt B.F. Targeted disruption of the PME-1 gene causes loss of demethylated PP2A and perinatal lethality in mice. PLoS ONE 3 (2008) e2486
74. Chen M.X., Chen Y.H., and Cohen P.T. Polymerase chain reactions using Saccharomyces, Drosophila and human DNA predict a large family of protein serine/threonine phosphatases. FEBS Lett 306 (1992) 54-58
75. Takai A., Sasaki K., Nagai H., Mieskes G., Isobe M., Isono K., et al. Inhibition of specific binding of okadaic acid to protein phosphatase 2A by microcystin-LR, calyculin-A and tautomycin: method of analysis of interactions of tight-binding ligands with target protein. Biochem J 306 Pt 3 (1995) 657-665
76. Perretti M., Ahluwalia A., Harris J.G., Harris H.J., Wheller S.K., and Flower R.J. Acute inflammatory response in the mouse: exacerbation by immunoneutralization of lipocortin 1. Br J Pharmacol 117 (1996) 1145-1154
77. Duncan G.S., Peers S.H., Carey F., Forder R., and Flower R.J. The local anti-inflammatory action of dexamethasone in the rat carrageenin oedema model is reversed by an antiserum to lipocortin 1. Br J Pharmacol 108 (1993) 62-65
78. Croxtall J.D. Flower RJ. Lipocortin 1 mediates dexamethasone-induced growth arrest of the A549 lung adenocarcinoma cell line. Proc Natl Acad Sci USA 89 (1992) 3571-3575
79. Taylor A.D., Christian H.C., Morris J.F., Flower R.J., and Buckingham J.C. An antisense oligodeoxynucleotide to lipocortin 1 reverses the inhibitory actions of dexamethasone on the release of adrenocorticotropin from rat pituitary tissue in vitro. Endocrinology 138 (1997) 2909-2918
80. Croxtall J.D., and Flower R.J. Antisense oligonucleotides to human lipocortin-1 inhibit glucocorticoid-induced inhibition of A549 cell growth and eicosanoid release. Biochem Pharmacol 48 (1994) 1729-1734
81. Roviezzo F., Getting S.J., Paul-Clark M.J., Yona S., Gavins F.N., Perretti M., et al. The annexin-1 knockout mouse: what it tells us about the inflammatory response. J Physiol Pharmacol 53 (2002) 541-553
82. Hannon R., Croxtall J.D., Getting S.J., Roviezzo F., Yona S., Paul-Clark M.J., et al. Aberrant inflammation and resistance to glucocorticoids in annexin 1-/- mouse. FASEB J 17 (2003) 253-255
83. Chatterjee B.E., Yona S., Rosignoli G., Young R.E., Nourshargh S., Flower R.J., et al. Annexin 1-deficient neutrophils exhibit enhanced transmigration in vivo and increased responsiveness in vitro. J Leukoc Biol 78 (2005) 639-646
84. Damazo A.S., Yona S., D'Acquisto F., Flower R.J., Oliani S.M., and Perretti M. Critical protective role for annexin 1 gene expression in the endotoxemic murine microcirculation. Am J Pathol 166 (2005) 1607-1617
85. D'Acquisto F., Merghani A., Lecona E., Rosignoli G., Raza K., Buckley C.D., et al. Annexin-1 modulates T-cell activation and differentiation. Blood 109 (2007) 1095-1102
86. D'Acquisto F., Paschalidis N., Sampaio A.L., Merghani A., Flower R.J., and Perretti M. Impaired T cell activation and increased Th2 lineage commitment in Annexin-1-deficient T cells. Eur J Immunol 37 (2007) 3131-3142
87. Taylor A.D., Christian H.C., Morris J.F., Flower R.J., and Buckingham J.C. Evidence from immunoneutralization and antisense studies that the inhibitory actions of glucocorticoids on growth hormone release in vitro require annexin 1 (lipocortin 1). Br J Pharmacol 131 (2000) 1309-1316
88. John C.D., Christian H.C., Morris J.F., Flower R.J., Solito E., and Buckingham J.C. Annexin 1 and the regulation of endocrine function. Trends Endocrinol Metab 15 (2004) 103-109
89. Croxtall J.D., Gilroy D.W., Solito E., Choudhury Q., Ward B.J., Buckingham J.C., et al. Attenuation of glucocorticoid functions in an Anx-A1-/- cell line. Biochem J 371 (2003) 927-935
90. Yona S., Buckingham J.C., Perretti M., and Flower R.J. Stimulus-specific defect in the phagocytic pathways of annexin 1 null macrophages. Br J Pharmacol 142 (2004) 890-898
91. Yona S., Ward B., Buckingham J.C., Perretti M., and Flower R.J. Macrophage biology in the Anx-A1-/- mouse. Prostaglandins Leukot Essent Fatty Acids 72 (2005) 95-103
92. Kay A.B., Walsh G.M., Moqbel R., MacDonald A.J., Nagakura T., Carroll M.P., et al. Disodium cromoglycate inhibits activation of human inflammatory cells in vitro. J Allergy Clin Immunol 80 (1987) 1-8
93. Bruijnzeel P.L., Warringa R.A., Kok P.T., Hamelink M.L., Kreukniet H., and Koenderman L. Effects of nedocromil sodium on in vitro induced migration, activation, and mediator release from human granulocytes. J Allergy Clin Immunol 92 (1993) 159-164
94. Szkudlinska B., Kowalski M.L., Grzegorczyk J., and Pierzchala A. Chemotactic activity of neutrophils from atopic and non-atopic subjects-effect of sodium cromoglycate (DSCG). Pneumonol Alergol Pol 64 (1996) 379-385
95. Dahlen S.E., Bjorck T., Kumlin M., Sydbom A., Raud J., Palmertz U., et al. Dual inhibitory action of nedocromil sodium on antigen-induced inflammation. Drugs 37 Suppl. 1 (1989) 63-68 [discussion 9-77]
96. Joseph M., and Rainey D.K. Basic research on nedocromil sodium. Rev Mal Respir 9 Suppl. 1 (1992) R93-R97
97. Yamawaki I., Tamaoki J., Takeda Y., and Nagai A. Inhaled cromoglycate reduces airway neurogenic inflammation via tachykinin antagonism. Res Commun Mol Pathol Pharmacol 98 (1997) 265-272
98. Rusznak C., Devalia J.L., Sapsford R.J., and Davies R.J. Ozone-induced mediator release from human bronchial epithelial cells in vitro and the influence of nedocromil sodium. Eur Respir J 9 (1996) 2298-2305
99. Sacco O., Lantero S., Scarso L., Galietta L.J., Spallarossa D., Silvestri M., et al. Modulation of HLA-DR antigen and ICAM-1 molecule expression on airway epithelial cells by sodium nedocromil. Ann Allergy Asthma Immunol 83 (1999) 49-54
100. Oliani S.M., Christian H.C., Manston J., Flower R.J., and Perretti M. An immunocytochemical and in situ hybridization analysis of annexin 1 expression in rat mast cells: modulation by inflammation and dexamethasone. Lab Invest 80 (2000) 1429-1438
101. Theoharides T.C., Wang L., Pang X., Letourneau R., Culm K.E., Basu S., et al. Cloning and cellular localization of the rat mast cell 78-kDa protein phosphorylated in response to the mast cell "stabilizer" cromolyn. J Pharmacol Exp Ther 294 (2000) 810-821
102. Theoharides T.C., Sieghart W., Greengard P., and Douglas W.W. Antiallergic drug cromolyn may inhibit histamine secretion by regulating phosphorylation of a mast cell protein. Science 207 (1980) 80-82
103. Bansal S.K., Jha A., Jaiswal A.S., and Chhabra S.K. Increased levels of protein kinase C in lymphocytes in asthma: possible mechanism of regulation. Eur Respir J 10 (1997) 308-313
104. Lucas A.M., and Shuster S. Cromolyn inhibition of protein kinase C activity. Biochem Pharmacol 36 (1987) 562-565
105. Sagi-Eisenberg R. Possible role for a calcium-activated phospholipid-dependent protein kinase in mode of action of DSCG. Trends Pharmacolo Sci 6 (1985) 198-200
106. Uzunoglu S., Uslu R., Tobu M., Saydam G., Terzioglu E., Buyukkececi F., et al. Augmentation of methylprednisolone-induced differentiation of myeloid leukemia cells by serine/threonine protein phosphatase inhibitors. Leukemia Res 23 (1999) 507-512
107. Oyama Y., Shishibori T., Yamashita K., Naya T., Nakagiri S., Maeta H., et al. Two distinct anti-allergic drugs, amlexanox and cromolyn, bind to the same kinds of calcium binding proteins, except calmodulin, in bovine lung extract. Biochem Biophys Res Commun 240 (1997) 341-347
108. Shishibori T., Oyama Y., Matsushita O., Yamashita K., Furuichi H., Okabe A., et al. Three distinct anti-allergic drugs, amlexanox, cromolyn and tranilast, bind to S100A12 and S100A13 of the S100 protein family. Biochem J 338 Pt 3 (1999) 583-589